Fundraising Fox

Fractyl

NASDAQ: GUTS

Lexington, US · Delaware corporation · 6 known investors

fractyl.com

Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms. The company serves patients and the physician community seeking alternatives to lifelong pharmaceutical treatments.

BiotechHealthtechMedical Devicesin /fractyl-health@fractylhealth

Founders & leadership

AW
ALLAN WILLDirector
SL
STANLEY LAPIDUSDirector
NS
NIMESH SHAHDirector
CG
CHRISTOPHER GABRIELIDirector
HR
HARITH RAJAGOPALANExecutive Officer, Director
JC
JAY CAPLANExecutive Officer, Director
LD
LISA DAVIDSONExecutive Officer
AR
AJAY ROYANDirector

Investors · 6

Reported raises · per SEC filings

Form D private placements
$20.1MraisedJan 2022 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • ALLAN WILLDirector
  • JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
  • CLIVE MEANWELLDirector
  • LISA DAVIDSONExecutive Officer
  • HARITH RAJAGOPALANExecutive Officer, Director
  • WILLIAM BRADLEYDirector
  • BRIAN DOVEYDirector
  • KELLY BARNESDirector
  • AMY SCHULMANDirector
  • JAY CAPLANExecutive Officer
  • MARC ELIADirector
  • AJAY ROYANDirector
Offering amount
$20.1M
Amount sold
$20.1M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100MraisedJun 2021 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • WILLIAM BRADLEYDirector
  • JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
  • ALLAN WILLDirector
  • CLIVE MEANWELLDirector
  • MARGARET BORYSExecutive Officer
  • JAY CAPLANExecutive Officer
  • MICHAEL HUANGDirector
  • LISA DAVIDSONExecutive Officer
  • MARC ELIADirector
  • HARITH RAJAGOPALANExecutive Officer, Director
  • BRIAN DOVEYDirector
  • AJAY ROYANDirector
  • AMY SCHULMANDirector
Offering amount
$100M
Amount sold
$100M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$44.8MraisedMar 2020 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • WILLIAM BRADLEYDirector
  • AMY SCHULMANDirector
  • JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
  • HARITH RAJAGOPALANExecutive Officer, Director
  • JAY CAPLANExecutive Officer
  • MARGARET BORYSExecutive Officer
  • LISA DAVIDSONExecutive Officer
  • JOHN AMATRUDADirector
  • CHRISTOPHER GABRIELIDirector
  • STANLEY LAPIDUSDirector
  • AJAY ROYANDirector
  • BRIAN DOVEYDirector
  • ALLAN WILLDirector
Offering amount
$44.8M
Amount sold
$44.8M
Finders' fees
$468K
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$44MraisedDec 2017 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • STANLEY LAPIDUSDirector
  • HARITH RAJAGOPALANExecutive Officer, Director
  • CHRISTOPHER GABRIELIDirector
  • LISA DAVIDSONExecutive Officer
  • AJAY ROYANDirector
  • JOHN AMATRUDADirector
  • ALLAN WILLDirector
  • BRIAN DOVEYDirector
  • JAY CAPLANExecutive Officer
  • WILLIAM BRADLEYDirector
Offering amount
$44M
Amount sold
$44M
Finders' fees
$250K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$47.2MraisedFeb 2016 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALLAN WILLDirector
  • STANLEY LAPIDUSDirector
  • NIMESH SHAHDirector
  • CHRISTOPHER GABRIELIDirector
  • AJAY ROYANDirector
  • HARITH RAJAGOPALANExecutive Officer, Director
  • JAY CAPLANExecutive Officer, Director
  • LISA DAVIDSONExecutive Officer
Offering amount
$47.2M
Amount sold
$47.2M
First sale
Oct 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news